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Cellular p53 protein levels are regulated by a ubiqui-
tination/de-ubiquitination cycle that can target the
protein for proteasomal destruction. The ubiquitina-
tion reaction is catalyzed by a multitude of ligases,
whereas the removal of ubiquitin chains is mediated
by two deubiquitinating enzymes (DUBs), USP7
(HAUSP) and USP10. Here, we show that PHD3 hy-
droxylates p53 at proline 359, a residue that is in
the p53-DUB binding domain. Hydroxylation of p53
upon proline 359 regulates its interaction with USP7
and USP10, and its inhibition decreases the associa-
tion of p53 with USP7/USP10, increases p53 ubiqui-
tination, and rapidly reduces p53 protein levels inde-
pendently of mRNA expression. Our results show
that p53 is a PHD3 substrate and that hydroxylation
by PHD3 regulates p53 protein stability through
modulation of ubiquitination.INTRODUCTION
p53 is a potent tumor suppressor that functions as a stress-acti-
vated transcription factor regulating a multitude of cellular re-
sponses including apoptosis, senescence, DNA repair, and cell
cycle arrest (el-Deiry et al., 1993; Levine, 1997; Li et al., 2012;
Warboys et al., 2014). Oxygen deprivation or hypoxia is among
the stresses that have been shown to induce p53 signaling lead-
ing to cell cycle arrest and apoptosis. The induction of p53
signaling appears to be dependent on the severity and duration
of the oxygen deprivation (Alarco´n et al., 1999; Graeber et al.,
1994; Hammond and Giaccia, 2005; Koumenis et al., 2001). In
addition to these dynamic regulations, in some cellular systems
hypoxia has the diametrically opposed effect and decreases p53
protein levels (Chen et al., 2010; Sermeus et al., 2013). The
reason why p53 responds to hypoxia in such a variable fashion
is not yet resolved, and the same pathways have been used to
explain both why p53 activity is induced or reduced by hypoxia.
p53 activity, localization, and stability are tightly regulated by a1316 Cell Reports 24, 1316–1329, July 31, 2018 ª 2018 The Author(s
This is an open access article under the CC BY license (http://creativevariety of post-translational modifications including ubiquitina-
tion, acetylation, phosphorylation, and hydroxylation (Bode
and Dong, 2004; Wang et al., 2014). Protein stability, as well as
localization, are regulated by mono- and poly-ubiquitination
mediated by ubiquitin ligases. Depending upon the cellular
context, a variety of E3 ligases are thought to be the rate-liming
factors in the regulation of p53 protein expression. One of these,
MDM2, is regarded as the master regulator not only of p53 pro-
tein levels but also of p53 localization in a variety of cellular sys-
tems (Michael andOren, 2003). Additionally, in cells infectedwith
human papilloma virus (HPV), the viral E6 protein promotes the
binding of p53 to the E3-ligase E6AP, which in turn ubiquitinates
p53 efficiently and severely reduces cellular p53 protein levels
(Talis et al., 1998).
Ubiquitination levels are not exclusively controlled by the for-
ward reaction of the ligases. The modification is reversible and
p53 is deubiquitinated by a family of proteases, the deubiquiti-
nases (DUBs), two of which, USP7 (HAUSP) and USP10, regu-
late p53 (Li et al., 2002; Sheng et al., 2006; Yuan et al., 2010).
In addition to ubiquitination, several post-translational modifi-
cations including hydroxylations affect p53 signaling. Transcrip-
tional activity is repressed by the hydroxylation of a C-terminal
lysine catalyzed by JMJD6, a hydroxylase previously shown to
act as histone demethylase and lysine hydroxylase (Wang
et al., 2014). Three additional hydroxylases regulate the broader
p53 pathway. FIH, an asparagine hydroxylase, hydroxylates the
p53 binding protein ASPP2 on a C-terminal residue (Janke et al.,
2013). Second, it was shown that PHD1, a proline hydroxylase,
can regulate p53 by mediating the p38a-dependent phosphory-
lation of serine 15 in response to chemotherapeutic drugs (De-
schoemaeker et al., 2015b). Finally, PHD3 enhances HCLK2
binding to ATR by hydroxylating several proline residues (Xie
et al., 2012). PHD3 has been most prominently linked to the
cellular response to hypoxia and is one of three PHDs shown
to destabilize HIF1/2a (Epstein et al., 2001). We identified p53
as an interaction partner of PHD3 in a substrate-trap assay
and were intrigued by this finding as regulation of p53 by
PHD3 could help explain why p53 expression levels are regu-
lated in a dynamic and non-linear fashion in hypoxic conditions.
With this in mind, we set out to identify if and by which mecha-
nism PHD3 directly regulates p53.).
commons.org/licenses/by/4.0/).
Figure 1. PHD3 Interacts with p53 in an Enzyme-to-Substrate-like Manner
(A) HEK293T cells were transfected in biological triplicates with an empty vector control, V5-tagged PHD1, PHD2, PHD3, or FIH. 24 hr post-transfection, the cells
were treated with DMSO or DMOG for 4 hr. The V5-tagged proteins and their binding proteins were immunoprecipitated, digested, and analyzed by mass
spectrometry. Bar graphs represent the LFQ intensities of p53 binding to the hydroxylases or a negative control. Error bars are SD, and n = 3.
(B) HEK293T cells were transfectedwith an empty vector control, V5-tagged PHD1, PHD2, PHD3, or FIH. 24 hr post-transfection, the cells were treated or not with
DMOG for 4 hr. The cells were lysed (TL), and V5-tagged proteins and their binding proteins were immunoprecipitated (IP), separated on PAGE, electroblotted,
and detected with the indicated antibodies.
(C) HEK293T cells were transfected with an empty vector control or V5-tagged PHD3, treated with DMOG for 4 hr or not, and lysed (TL). Cell lysates were
incubated with bacterial expressed GST-p53 or GST bound to agarose beads for 2 hr. GST-pull-downs (PD) were washed, separated by PAGE, and electro-
blotted, and proteins were detected by the indicated antibodies.
(legend continued on next page)
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RESULTS
PHD3 Interacts with p53
Using quantitativemass spectrometry and a substrate ‘‘trapping’’
approach, we set out to identify substrates of HIF hydroxylases in
HEK293T cells (Cockman et al., 2009; Rodriguez et al., 2016). In-
cubationwith dimethyloxaloylglycine (DMOG), a pan-hydroxylase
inhibitor, blocks the hydroxylase reaction and prevents the disso-
lution of the hydroxylase enzyme-substrate complex, increasing
the enzyme-substrate complex. Quantifying dynamic, DMOG-
dependent changes of the interactome allows for the distinction
between generic interactors and likely substrates.We transfected
HEK293T cells either with an empty vector or a V5-tagged hy-
droxylase and treated the cells with DMOG. Subsequently, the
V5 immunoprecipitated proteins were identified and quantified
by label-free quantification (LFQ) (Tate et al., 2013).
Using this approach, we detected the formation of a complex
between PHD3 and p53 in normoxic conditions and additionally
detected that this interaction was induced upon DMOG treat-
ment (Figure 1A). We further confirmed the specificity of the
interaction by immunoprecipitation and western blot (Figure 1B).
These results suggested that p53 could be a novel substrate of
PHD3. To determine whether this interaction could be reconsti-
tuted in vitro, we performed a glutathione S-transferase (GST)
pull-down assay of recombinant V5-PHD3, using GST-p53 and
GST as baits. We detected that p53 bound PHD3 and that incu-
bation with DMOG increased the interaction, suggesting that
p53 binds PHD3 directly (Figure 1C). In contrast, we were not
able to reconstitute the postulated complex between HIF1a
and p53 (Hansson et al., 2002) under our experimental condi-
tions, probably related to a post-translational modification that
is required on p53, which does not occur in our bacterial expres-
sion system.
To determine whether the induced interaction between p53
and PHD3 was not due to an off-target effect of DMOG, we
compared the effect of the pan-hydroxylase inhibitor DMOG
(which inhibits both PHDs and FIH) to the PHD-selective, struc-
turally unrelated inhibitor JNJ-42041935 (JNJ) (Barrett et al.,
2011). We observed that the p53/PHD3 complex was induced
by both (Figure 1D). To analyze whether the active center of
PHD3 was required for the interaction, we used two catalytically
dead mutants of PHD3: H196A and HD135/137AA, which are
mutated at the residues required for the correct iron binding
(Bruick and McKnight, 2001). We immunoprecipitated endoge-
nous p53 and observed that the interaction between p53 and
PHD3 was absent in the case of both catalytically dead mutants
(Figure 1E).
These results demonstrated that the interaction is direct and
requires the presence of the intact prolyl hydroxylase active cen-
ter, and inhibiting the hydroxylase with small chemical inhibitors
‘‘traps’’ the complex. These data suggest that the interaction be-
tween PHD3 and p53 is one of an enzyme to substrate.(D) HEK293T cells were transfected with an empty vector control or V5-tagged PH
for 4 hr. The cells were lysed, and V5-tagged proteins and their binding proteins we
the indicated antibodies.
(E) HEK293T cells were transfected with an empty vector or PHD3wt, H196A, or H
for 4 hr. Endogenous p53 was immunoprecipitated, separated on PAGE, and ele
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HEK293T is a good cell model for analysis of protein-protein in-
teractions as it maintains a high transfection efficiency even
when using low amounts of DNA to allow for expression of
tagged proteins close to physiological levels (Rodriguez et al.,
2016). However, this cell line is not a good model of p53
signaling, as HEK293Ts express adenoviral oncoproteins e1a/
e1b55k, which prevents p53 activation and degradation (Grand
et al., 1999; Lowe and Ruley, 1993). Thus, we decided to analyze
the effect of hydroxylase inhibition in two cell line models with
wild-type (wt) p53 expression, but divergent regulation: HeLa
cells, in which p53 degradation is mediated by the E6 oncopro-
tein (Hoppe-Seyler and Butz, 1993), and HepG2 cells, in which
p53 stability is controlled by the action of MDM2 (Lu et al., 2000).
In HeLa cells, we observed that DMOG reduced endogenous
p53 protein levels. This suppression could be rescued by
MG132, an inhibitor of the 26S proteasome (Lee and Goldberg,
1998) (Figure 2A) and that p53 reduction was not limited to either
nuclear or cytoplasmic localization (Figure S1A). We further
showed that that hydroxylase inhibition had no effect on p53
mRNA levels in our experimental setup (Figure 2B), indicating
that in HeLa cells the reduction of p53 levels by DMOG was
mediated via proteasomal degradation. Additionally, to exclude
that the reduction of p53 protein levels was due to the regulation
of the translational machinery, we incubated the cells with cyclo-
heximide (CHX), which has been shown to block the elongation
phase of eukaryotic translation (Obrig et al., 1971). Pre-treating
HeLa cells with DMOG reduced p53 protein half-life assayed
by a CHX-chase experiment in HeLa cells (Figure 2C).
These data suggest that hydroxylase inhibitors affect p53 protein
levels by post-translational targeting for destruction via the
proteasome.
Since hydroxylase inhibitors regulated p53 protein stability in
HeLa cells, we wanted to determine whether endogenous
PHD3 and p53 also interacted in these cells. We immunoprecip-
itated endogenous PHD3 or p53 and were able to detect p53 in-
teracting with the PHD3 and vice versa (Figure 2D). Finally, we
wanted to verify whether the reduction of p53 upon hydroxylase
inhibition was mediated by PHD3. We transfected HeLa cells
with either siNT (non-targeting small interfering RNA [siRNA]) or
siPHD3 (siRNA specifically targeting PHD3) and observed that
knockdown of PHD3 was sufficient to reduce p53 protein levels
under normoxic conditions (Figure 2E). Under hypoxic condi-
tions, cellular PHD3 activity can be reduced due to reduced ox-
ygen tension or, counterintuitively, enhanced because of the
strong induction of PHD3 protein expression. This non-linear
behavior of global PHD3 activity in hypoxia may reduce or
enhance p53 protein levels depending on the cellular and envi-
ronmental context. To see whether we could detect such non-
linearity, we incubated HeLa cells in DMOG or 1% oxygen for
up to 24 hr, by which time PHD3 protein levels are induced.
Upon DMOG treatment, p53 levels quickly decrease and recoverD3. 24 hr post-transfection, the cells were treated with DMSO, DMOG, or JNJ
re immunoprecipitated, separated on PAGE, electroblotted, and detectedwith
D135/137AA. 24 hr post-transfection, the cells were treated or not with DMOG
ctroblotted, and proteins were detected with the indicated antibodies.
Figure 2. PHD3 Regulates p53 Protein Stability
(A) HeLa cells were treatedwith DMOG for 4 hr in the presence or absence ofMG132. Cells were lysed, and proteins were separated by PAGE, electroblotted, and
detected by the indicated antibodies.
(B) HeLa cells were treated with DMSO or DMOG, and after 4 hr cells were harvested for quantitative RT-PCR assays. The expression level of p53 was normalized
to endogenous actin mRNA levels. The values plotted are means ± SD of N = 3 independent experiments for each condition. In parallel, a western blot was
performed to validate DMOG treatment.
(legend continued on next page)
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at later time points. We observed an induction of p53 mRNA; we
cannot therefore exclude that the induction of p53 protein levels
is due to enhanced transcription (Figure 2F). In hypoxia, to our
surprise, we could not detect p53 levels rebounding, despite
an increase in the underlying p53 mRNA signal, suggesting
that in this cell line PHD3 activity is suppressed in 1% oxygen
(Figure 2G). Overexpression of exogenous PHD3 in HeLa cells
did not reproducibly increase p53 levels, but re-expression of
exogenous PHD3 rescued p53 protein levels following PHD3
knockdown (Figures S1B and S1C).
We went on to perform similar experiments in HepG2 cells,
in which MDM2 is the main regulator of p53 stability. We
analyzed the effect of two structurally distinct hydroxylase in-
hibitors and hypoxia on p53 protein levels and observed that
hydroxylase inhibition led to the reduction of p53 levels. We
observed that MG132 blocked the reduction of p53 triggered
by DMOG or JNJ (Figure 3A) and further confirmed that the
reduction of the p53 protein levels was not due to a suppres-
sion of mRNA levels (Figures 3B, S2A, and S2B). In light of this
result, we assayed p53 protein stability in HepG2 cells and
determined that p53 protein half-life was reduced in the pres-
ence of DMOG (Figure 3C). To check whether this was medi-
ated by PHD3 activity, we knocked down PHD3 and moni-
tored p53 expression. PHD3 knockdown was sufficient to
reduce p53 levels under normoxic and hypoxic conditions
(Figure 3D). This reduction in p53 levels was linked with an
increase of the proteasomal degradation as the treatment
with the proteasomal inhibitor MG132 rescued this reduction
(Figure 3E). We could not observe that prolonged hypoxia
or DMOG treatment led to p53 levels rebounding together
with increasing PHD3 levels and that overexpression of
PHD3 did not significantly stabilize p53 level in normoxia (Fig-
ures S2A–S2C). We could nevertheless rescue p53 expression
levels by re-expressing exogenous PHD3 in cells where PHD3
had been knocked down by siRNA (Figure S2D).
An increase in proteasomal degradation is associated with
ubiquitination of the protein. To determine whether hydroxylase
inhibition increased p53 ubiquitination, we precipitated ubiquiti-
nated proteins by tandem ubiquitin binding entities (TUBEs) pull-
downs in HepG2 cells incubated with or without DMOG and
MG132. We detected that DMOG increased p53 ubiquitination
compared to the untreated sample (Figure 3F). These results
suggest that hydroxylase inhibitors and PHD3 specifically pro-
mote a reduction in p53 levels via an ubiquitination-dependent
proteasomal mechanism.(C) HeLa cells were incubated with DMOG or DMSO for 4 hr and treated afterwar
were separated by PAGE, electroblotted, and detected by the indicated antibod
were plotted on an xy diagram with log(2)-transformed x-axis to visualize protein
(D) HeLa cells were treated with or without DMOG for 4 hr. The cells were lysed
immune antibody as negative control (PreI). Total lysates and the corresponding i
(E) HeLa cells were transfected with non-targeting (NT) or PHD3-specific siRNA
proteins were separated by PAGE, electroblotted, and detected by the indicated
(F) HeLa cells were treatedwith DMOGas indicated and lysed, and proteinswere s
parallel, mRNA was extracted and quantified by RT-PCR (second panel).
(G) HeLa cells were cultured in 1% oxygen as indicated and lysed, and proteins
bodies. In parallel, mRNAwas extracted and quantified by RT-PCR (second panel
condition.
Two-tailed, equal distribution Student’s t test was employed to test for statistica
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Having determined that the activity of PHD3 is required for p53
stability, we tested whether p53 can be directly hydroxylated
by PHD3. Initially, we performed an in vitro hydroxylation assay
with HEK293T lysate overexpressing V5-PHD3 in conjunction
with recombinant GST-p53 as substrate and detected hydroxyl-
ated prolines by liquid chromatography-tandem mass spec-
trometry (LC-MS/MS). In total, we were able to detect nine hy-
droxyprolines in GST-p53 after the in vitro hydroxylation
reaction (Figures S3A–S3I). Following on from this exploratory
analysis, we determined whether any of these hydroxylation
sites could be detected in vivo and were regulated by PHD3
activity.
Using Flag-p53 as substrate, we performed an in vivo hydrox-
ylation assay in which we utilized two opposing extreme condi-
tions. In one, we induced hydroxylation levels by overexpressing
V5-PHD3, and in the other we suppressed levels of protein hy-
droxylation by treating the cells with DMOG. In a comparative
analysis between these two experimental conditions, we were
only able to identify one of the previously detected hydroxypro-
lines (Figure S4A) and observed a reduction of this hydroxylation
upon DMOG treatment. The hydroxylation site identified was
located at proline 359, which lies in the C-terminal domain of
p53 (Figure 4A). Additionally, in order to confirm that PHD3 is
one of the enzymes that promote the hydroxylation of Pro359
in an oxygen-dependent manner, we analyzed the effect of
PHD3 siRNA and hypoxia on the hydroxylation levels. We
observed that the hydroxylation of P359 decreased in cells trans-
fected with PHD3 siRNA and that 1% oxygen reduced hydroxyl-
ation levels below the limit of detection, supporting the concept
that Pro359 is a target of a PHD3 and oxygen-dependent hy-
droxylation (Figure 4B).
To confirm that PHD3 directly hydroxylates P359, we incu-
bated a biotinylated peptide (amino acids 349–371 of human
p53) with extracts of HEK293T cells overexpressing PHD3 wt
or the inactive mutant PHD3 H196A and observed an increase
of proline 359 hydroxylation when the peptide was incubated
with PHD3 wt in comparison to the inactive hydroxylase. As an
internal control, the oxidation levels of the biotin residue were
also monitored, which showed no difference (Figures 4C and
S4B). Last, we incubated purified, recombinant PHD3 with the
peptide and could confirm the hydroxylation (Figure S4C).
To demonstrate that PHD3 interacts with the peptide, we incu-
bated lysates overexpressing PHD3 wt or the inactive mutant
with the peptides. We detected the interaction of PHD3 wt withd with/without CHX (10 mg/mL) for up to 30 min. Cells were lysed, and proteins
ies. p53 intensity normalized to the respective (DMOG or DMSO) 0-time point
half-life.
(TL) and endogenous PHD3 or p53 was immunoprecipitated (IP), using a pre-
mmunoprecipitates were probed for the indicated proteins for immunoblotting.
. 48 hr post-transfection, the cells were treated with DMOG and lysed, and
antibodies.
eparated by PAGE, electroblotted, and detected by the indicated antibodies. In
were separated by PAGE, electroblotted, and detected by the indicated anti-
). The values plotted aremeans ±SD of N = 3 independent experiments for each
l difference with values of **p < 0.01 and ***p < 0.001
Figure 3. PHD3 Regulates p53 Protein Stability and Ubiquitination
(A) HepG2 cells were treated with DMOG of JNJ for 4 hr in the presence or absence of MG132. Cells were lysed, and proteins were separated by PAGE,
electroblotted, and detected by the indicated antibodies.
(B) HepG2 cells were treated with DMOG, and after 4 hr, cells were harvested for quantitative RT-PCR assays. The expression level of p53 was normalized to
endogenous actin mRNA levels. The values plotted are means ± SD of N = 3 independent experiments for each condition. In parallel, a western blot was per-
formed to validate DMOG treatment.
(C) HepG2 cells were incubated with DMOGor DMSO for 2 hr and treated afterward with/without CHX (10 mg/mL) for up to 120min. Cells were lysed, and proteins
were separated by PAGE, electroblotted, and detected by the indicated antibodies. p53 intensity normalized to the respective (DMOG or DMSO) 0-time point was
plotted on an xy diagram with log(2)-transformed x-axis to visualize protein half-life.
(D) HepG2 cells were transfected with non-targeting (NT) or PHD3-specific siRNA. 24 hr post-transfection, the cells were placed in a hypoxia chamber (Coy
Laboratories, Grass Lake, MI) during 24 hr (1% O2, 5% CO2, and 94% N2). Normoxic controls were maintained at atmospheric O2 levels (21% O2, 5% CO2, and
(legend continued on next page)
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the peptide but were unable to detect the interaction of
PHD3 H196A (Figure 4D). To determine that proline 359 was
essential for the binding of the hydroxylase with the peptide,
we synthesized the analogous peptide exchanging proline 359
for hydroxyproline. We then incubated the proline- and hydroxy-
proline-containing peptides with lysates overexpressing PHD3
and observed that hydroxylation of proline 359 reduced the bind-
ing of the peptide to PHD3 (Figure 4E).
In light of these results, we tested whether the DMOG-induced
reduction of p53 protein levels required the presence of proline
359 in p53. We generated a mutant of p53, where proline was
exchanged for alanine (P359A), and expressed the Flag-tagged
mutant and wt p53 in HepG2. We readily detected the reduction
of Flag-p53wt and of the endogenous protein (Figure 4F). P359A
mutant levels were not reduced by DMOG treatment. Proline-to-
alanine mutations can alter the secondary structure of
the protein; therefore, to ascertain that the insensitivity of the
P359A mutant was not due to an unspecific disruption of the
structure, we mutated two neighboring proline to alanine
(P316/318A) and repeated the assay. In contrast to the P359mu-
tation, p53 P316/318A protein expression behaved analogously
to the wt protein (Figure 4G). These results show that PHD3 hy-
droxylates p53 at the Pro359 and that the hydroxylation of this
residue regulates p53 stability.
Asmentioned previously, PHDs regulate upstream effectors of
the p53 signaling network, whichmanifests in the modification of
p53 phosphorylation on serine 15. To ascertain that phosphory-
lation of this residue is not causal to the reduction of p53 protein
levels upon hydroxylase inhibition, we mutated this residue to
alanine (S15A). We repeated the assay and observed that p53
S15A expression was also reduced by DMOG treatment (Fig-
ure 4H), demonstrating that this downregulation of p53 is inde-
pendent of S15 phosphorylation.
Hydroxylation of P359 Regulates the Binding
of p53-USP7/10
Having demonstrated P359 hydroxylation and consequent regu-
lation of p53 stability, we pursued approaches that would reveal
the underlying molecular mechanism. Proline hydroxylation
generally affects protein-protein interactions. Consequently,
we used an unbiased approach to determine how hydroxylase
inhibitors affected the interactome of exogenous Flag-p53. Us-
ing a quantitative mass spectrometry approach and focusing
on ubiquitin ligases and proteases, we were able to determine
that the interaction between p53 and two DUBs, USP7 and
USP10, was reduced under DMOG treatment (Figure 5A).
USP7 interacts and regulates p53 as well as MDM2 stability by
promoting their deubiquitination (Li et al., 2002; Ma et al.,
2010). The interaction of USP7 with p53 is well characterized,
and amino acids 359–367 have been identified as responsible74% N2) in a tissue culture incubator. After this time, the cells were lysed and pro
antibodies.
(E) HEPG2 cells were transfected with non-targeting (NT) or PHD3-specific siRNA
PAGE, electroblotted, and detected by the indicated antibodies.
(F) HepG2 cells were treated with DMOG and/or MG132 for 2 hr. Cells were lysed
were separated by PAGE and electroblotted. Ubiquitinated p53 was detected by
separately (TL).
1322 Cell Reports 24, 1316–1329, July 31, 2018for p53 binding to USP7 (Sheng et al., 2006). USP10 also pro-
motes the deubiquitination of p53 (Yuan et al., 2010), although
the precise interaction domain within p53 has not yet been map-
ped. To confirm our mass spectrometry data by alternative
means, we immunoprecipitated exogenous Flag-tagged USP7
in HEK293T cells and observed that DMOG reduced the binding
between Flag-USP7 and endogenous p53 (Figure 5B). To further
confirm that the interaction required Pro359 hydroxylation, we
expressed Flag-USP7, His p53, and His p53 P359A in
HEK293T cells and immunoprecipitated His-tagged p53 in the
presence or absence of DMOG. We observed that DMOG and
themutation of Pro359 strongly reduced the interaction between
p53 and USP7 (Figure 5C).
To confirm the hydroxylation-dependent regulation of the p53-
USP10 interaction, we performed an analogous experiment.
Flag-p53 wt and Flag-p53 P359A were transfected into
HEK293T cells and immunoprecipitated. Similar to what we
observed with USP7, inhibition of hydroxylase activity dimin-
ished the interaction between p53 and endogenous USP10.
Furthermore, P359A mutation reduced the interaction with
USP10 in comparison to p53 wt and the interaction between
the p53-P359A and USP10 was not regulated by DMOG (Fig-
ure 5D). To unequivocally determine that hydroxylation of P359
enhances binding to USP, we incubated peptides containing
proline or hydroxyproline 359 with lysates overexpressing
USP7 or USP10 and observed that hydroxylation of proline 359
increased the binding of the peptide to both USPs (Figure 5E).
We additionally confirmed the interaction endogenously by im-
munoprecipitating USP10 from HepG2 cells treated with
DMOG or not and detecting co-purifying p53 (Figure S5A). To
determine whether the absence of a USP7/10 binding site on
p53 increased p53 ubiquitination, we transfected Flag-p53 wt
and Flag-p53 P359A into HepG2 cells and precipitated ubiquiti-
nated proteins by TUBE pull-downs.We detected that the P359A
mutant had higher ubiquitination levels when compared to the wt
(Figure S5B).
These results show that DMOG reduces the interaction be-
tween p53 and USP7/10, Pro359 is required for binding with
both USPs, mutation of Pro359 to alanine eliminates the
DMOG sensitivity of the interaction, and hydroxylation of
Pro359 enhances p53-USP7/10 binding.
To establish whether the reduction of p53 under hydroxylase
inhibition was due to reduced DUB activity or binding, we trans-
fected HepG2 cells with siNT or siRNA targeting USP10
(siUSP10). In accordance with published work, we detected
that knockdown of USP10 is sufficient to reduce p53 protein
levels (Yuan et al., 2010). Treatment of the knockdown cells
with DMOG did not further reduce p53 levels (Figure 5F). In sum-
mary, these results demonstrate that the loss of hydroxylation of
Pro359 reduces the interaction between p53 and USP7/10. Inteins were separated by PAGE, electroblotted, and detected by the indicated
. 48 hr post-transfection, the cells were lysed, and proteins were separated by
and ubiquitinated proteins were precipitated with TUBE-agarose (PD). Proteins
a specific antibody (PD), and changes in expression in total lysate were blotted
Figure 4. p53 Is Hydroxylated on Pro359 by PHD3
(A) HEK293T cells were transfected with Flag-p53, an empty vector control, or V5-tagged PHD3. 24 hr post-transfection, the cells were treated with DMSO or
DMOG for 4 hr. Flag-p53 was immunoprecipitated, digested with Lys-C, and analyzed bymass spectrometry. Bar graph represents the normalized hydroxylation
ratio of p53 peptide. Error bars represent SEM, and n = 2.
(legend continued on next page)
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addition, we show that loss of USP10 mimics the effects of hy-
droxylase inhibition and that hydroxylase inhibition and USP10
knockdown are not additive, thus likely part of the same mecha-
nism regulating p53 protein stability under these circumstances.
Reduction of p53 Hydroxylation Reduces p53 Signaling
p53 is a key regulator of antiproliferative and apoptotic re-
sponses. In light of our data demonstrating the PHD3-dependent
regulation of p53 via hydroxylation of P359, we hypothesized
that inhibition or knockdown of PHD3 may regulate signaling
downstream of p53. PHD3 has been shown to promote p53-
mediated apoptosis in response to DNA-damaging agents by
hydroxylating HCLK2 and activating S15 phosphorylation on
p53 (Xie et al., 2012). In light of this report, we decided not to
induce p53 expression or activity through DNA damage or other
stress responses as it would be impossible to separate the effect
mediated by P359 hydroxylation from upstream events.
Working within these constraints, we determined whether
DMOG by itself affected p53 transcriptional activity by observing
expression levels of p21, a prominent p53 effector (el-Deiry et al.,
1994; Sheikh et al., 1994). In HepG2 cells, DMOG not only
reduced p53 levels but also markedly reduced p21 expression
(Figure 6A).
To determine whether the hydroxylase-dependent reduction
of p53/p21 affected systemic p53 signaling, we analyzed
whether expression and activity of PHD3 affected p53-induced
cell cycle arrest. To avoid crosstalk from stress-response path-
ways, we induced p53 and cell cycle arrest with nutlin-3, a chem-
ical inhibitor of MDM2-dependent degradation. Nutlin-3 stabi-
lized p53 protein levels but was not able to rescue the
reduction of p53 in response to PHD3 knockdown or inhibition,
confirming that the functional MDM2 and PHD3 act indepen-
dently of each other (Figure S6A). Nutlin-3 treatment was suffi-
cient to stabilize p53 and increase the percentage of cells in
G1 (Vassilev, 2004) in HepG2 cells. As reported, knockdown of
PHD3 increased cells in G1 (Ho¨gel et al., 2011). Nutlin-3 stabi-
lized p53 and increased the G1 population. PHD3 knockdown
partially rescued p53 stabilization and the proportional increase
of cells in G1 (Figures 6B, 6C, and S6B).(B) HEK293T cells were transfected with Flag-p53 in the presence of a non-targetin
in hypoxia for 24 hr. Flag-p53 was immunoprecipitated, digested with LysC, and
ratio modified/unmodified peptide intensities. Error bars represent SEM, and n =
(C) Biotinylated peptides ELKDAQAGKEPGGSRAHSSHLKS were incubated wi
or inactive mutant H196A. Bar graphs represent the ratio of the intensities of t
XIC of biotin(ox)-ELKDAQAGKEPGGSRAHSSHLKS (left peak) and biotin-ELK
KEPGGSRAHSSHLKS (black).
(D) HEK293T cells were transfected with the indicated PHD3 plasmids (ev, HA-PH
peptide. P359A peptide was bound previously to streptavidin agarose beads, and
the corresponding total lysates were tested by western blot for the indicated pro
(E) HEK293T cells were transfected with empty vector or V5-PHD3 plasmid. The c
with the two different peptides. Pull-down was performed using as a bait differen
bound previously to streptavidin agarose beads. Streptavidin agarose beads we
were tested by western blot for the indicated proteins.
(F) HepG2 cells were transfected with Flag-p53 wt or P359A mutant. 24 hr pos
separated on PAGE, electroblotted, and detected with the indicated antibodies.
(G) HepG2 cells were transfectedwithwt and P359A and P316/318Amutants of Fl
corresponding total lysates were tested by western blot for the indicated protein
(H) HEK293T cells were transfected with empty vector (control), Flag-p53 wt, Flag
with DMOG or DMSO for 4 hr. Total lysates were analyzed by western blotting fo
1324 Cell Reports 24, 1316–1329, July 31, 2018An additional model to study the role of p53 independent of
upstream stress pathways is the previously characterized doxy-
cycline (DOX)-inducible p53 Saos-2 cell line (Nakano et al.,
2000). We initially tested whether hydroxylase inhibitors affected
the DOX induction of p53 mRNA. JNJ did not affect the DOX-
dependent induction of p53 mRNA levels, whereas DMOG
severely reduced them, likely through an off-target effect on
the DOX induction (Figure S6C). In light of these data, we
decided to proceed with JNJ alone in this cell line.
JNJ reduced p53 levels (Figure 6D). We further confirmed that
reduction of PHD3 expression by siRNA was sufficient to reduce
p53 levels (Figure 6E). Suppression of p53 coincided with a
reduction of p21 upon hydroxylase inhibition and PHD3 knock-
down. In this inducible model, it has been shown that induction
of p53 by DOX robustly induces apoptosis. Using YO-PRO1 as
a marker of apoptosis, we observed that p53 induction by
DOX-induced apoptosis, which could be partially rescued by
PHD3 knockdown (Figures 6F and S6D).
Overall, we could confirm that inhibition or knockdown of
PHD3 reduced p53 and p21 levels in both model systems. Given
the clear effects on p53 levels and activity, it is perhaps surpris-
ing that the effects of PHD3 inhibition on p53-dependent cell cy-
cle arrest and apoptosis are not stronger. However, it is likely that
PHD3 inhibition affects cell cycle and survival pathways, which
may limit the magnitude of the observed rescues.
PHD3 expression is frequently attenuated in high-grade gli-
omas (Henze et al., 2014), and we hypothesized that re-expres-
sion of the active PHD3 may stabilize p53 and impede cell prolif-
eration and apoptosis in cell lines where PHD3 is silenced. To
test this hypothesis, we re-expressed PHD3 in U87, a glioma
cell line where PHD3 is silenced (Sciorra et al., 2012). To control
that the effects of PHD3 re-expression were mediated by p53,
we also infected the cells either with a scrambled or p53-specific
short hairpin RNA (shRNA). Re-expression of wt PHD3 but not
the inactive mutant by adenoviral infection led to a stabilization
of p53 and cleavage of caspase 3 (Figure 6G). Knocking down
p53 impaired caspase cleavage, indicating that PHD3-induced
caspase cleavage required p53. In addition, re-expression of
PHD3 impeded U87 cell proliferation, which was again partiallyg (NT) or PHD3-specific siRNA. 48 hr post-transfection, the cells were cultured
analyzed by mass spectrometry. Bar graphs represent the normalization of the
2. XIC of EP(ox)GGSRAHSSHLK and non-hydroxylated EPGGSRAHSSHLK.
th lysates derived from HEK293T cells transiently transfected with PHD3 wt
he modified and unmodified peptide. Error bars represent SEM, and n = 2.
DAQAGKEP(ox)GGSRAHSSHLKS (blue) and non-hydroxylated ELKDAQAG
D3 wt or PHD3 H135A/D137A). Pull-down was performed using as a bait P359
streptavidin agarose beads were used as a negative control. Pull-downs and
teins.
ellular lysate, overexpressing V5-PHD3, was split in two for further pull-downs
t P359 peptides (wt and hydroxylated at the proline 359). These peptides were
re used as a negative control. Pull-downs and the corresponding total lysates
t-transfection, the cells were treated with DMOG for 4 hr. Total lysates were
ag-p53. After 24 hr, the cells were treatedwith DMSO or DMOG for 4 hr, and the
s.
-p53 S15A, or Flag-p53 P359A for 24 hr. Following this time, cells were treated
r the indicated proteins.
Figure 5. p53 Hydroxylation on Pro359 Regulates the Binding of USP7/10
(A) HEK293T cells were transfected with Flag-p53. 24 hr post-transfection, the cells were treated with DMSO or with DMOG for 4 hr. Flag-p53 was immuno-
precipitated, digested with trypsin, and analyzed bymass spectrometry. Bar graphs represent the normalized LFQ intensities of USP7 or USP10 co-precipitating
with p53. Error bars are SD, and n = 2.
(B) HEK293T cells were transfected with Flag-USP7. 24 hr post-transfection, the cells were treated with DMSO or DMOG for 4 hr. Immunoprecipitation with anti-
Flag beads was followed by western blot analysis with the indicated antibodies.
(C) HEK293T cells were transfected with Flag-USP7 and/or wt or P359Amutant His-tagged p53. 24 hr post-transfection, the cells were treated or not with DMOG
for 4 hr. His-tagged proteins were immunoprecipitated. Proteins were separated by PAGE, electroblotted, and detected with the indicated antibodies.
(D) HEK293T cells were transfected with Flag-p53 wt or P359A mutant. 24 hr post-transfection, the cells were treated or not with DMOG for 4 hr. Immuno-
precipitation with anti-Flag beads was followed by western blot analysis with the indicated antibodies.
(E) HEK293T cells were transfected with empty vector or Flag-tagged USP7 or 10 plasmids. The cellular lysate, overexpressing USPs, was split in three
for further pull-downs with the two different peptides and a streptavidin-only control. 1% of the volume was kept as total lysate. Pull-down was
performed using as a bait different P359 peptides (wt and hydroxylated at the proline 359). These peptides were bound previously to streptavidin agarose beads.
(legend continued on next page)
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rescued by knocking-down p53 (Figure 6H). Third, transient
transfection of PHD3 robustly induced cellular DNA fragmenta-
tion, which was diminished upon p53 knockdown (Figures 6I
and S6E).
These data confirm our hypothesis that PHD3 regulates p53
stability and that the reported antiproliferative/proapoptotic func-
tions of PHD3 are partially mediated by p53. Nevertheless,
despite a near-complete knockdown of p53, PHD3 expression
still exhibited pronounced pro-apoptotic and anti-proliferative ef-
fects, indicating that only a part of the PHD3-dependent stress
signaling requires p53. These data are in line with previous find-
ings demonstrating that PHD3 elicits apoptotic or antiproliferative
signaling independent of p53 through KIF1Bb, by modulating
EGFR signaling, through acetyl-coA carboxylase 2 or by inducing
protein aggregates (German et al., 2016; Henze et al., 2014; Lee
et al., 2005; Rantanen et al., 2008; Schlisio et al., 2008).
DISCUSSION
It has been known for decades that hypoxia and hydroxylase in-
hibition regulate expression and activity of p53. Nevertheless,
the direction and amplitude of the regulation appear to be
controversial, with many studies reporting an increase, a
decrease, or no effect on protein levels at all (Pan et al., 2004).
At first sight, these results appear to be contradictory, but given
the highly complex regulation of p53 by a multitude of transla-
tional, post-translational, and feedback regulations, this should
not be surprising. We can observe these discrepancies in our
own data. p53 levels are transiently reduced in HeLa cells
upon DMOG treatment, whereas HepG2 respond in a sustained
manner. We assume that the combinatorial effect of PHD3, p53,
oxygen, and tricarboxylic acid (TCA) cycle intermediates all play
a role in shaping the response. As an example, there are data
suggesting that part of stress signaling following hypoxia/reoxy-
genation cycles is dependent on p53 (Gogna et al., 2012; Wein-
mann et al., 2004). We hypothesized that high levels of PHD3
combined with normoxic oxygen concentration upon reoxyge-
nation could lead to the rapid stabilization of p53, priming the
stress response. We tested this hypothesis in HepG2 cells.
24 hr in hypoxia induced PHD3 and reduced p53 as well as
p21 protein levels (Figures 6J and S6F). We observed that,
upon reoxygenation, p53 and p21 were stabilized within 1 hr.
This stabilization was PHD3 dependent as knockdown of
PHD3 not only reduced p53 levels in normoxia, but also pre-
vented the induction of p53 and p21 upon reoxygenation. Never-
theless, it is obvious that hydroxylation of p53 on P359 is only a
part of the overall picture. Hydroxylases themselvesmediate p53
activity, stability, and localization at multiple levels (Deschoe-
maeker et al., 2015a; Janke et al., 2013; Wang et al., 2014; Xie
et al., 2012), and recently the PHD1-dependent hydroxylation
of p53 has been postulated (Ullah et al., 2017). Such distributed
controls are common in most signaling pathways, and it is
emerging that the HIF pathway itself is regulated by hydroxyl-Streptavidin agarose beads were used as a negative control. Pull-downs and t
proteins.
(F) HepG2 cells were transfected with non-targeting (NT) or USP10-specific siRNA
Total lysates were analyzed by western blotting for the indicated proteins.
1326 Cell Reports 24, 1316–1329, July 31, 2018ation at multiple levels. Apart from enabling the VHL-HIF1/2a
interaction (Ivan et al., 2001; Jaakkola et al., 2001), hydroxylases
regulate the HIF1/2a interaction with p300 through hydroxylation
of a C-terminal residue (Hewitson et al., 2002). In addition, it was
recently shown that PHD1 can hydroxylate and activate DYRK1
kinases, which phosphorylate ID2 and prevent the disruption of
the VHL degradation complex, which in turn destabilizes HIF2a
(Lee et al., 2016). The realization of the increasing complexity
with numerous feedforward and feedback loops can already
explain some ostensibly contradictory reports. This highlights
the necessity of doing experiments with sufficient temporal res-
olution across multiple model systems and, if possible, to
generate mathematical models based on these data.
EXPERIMENTAL PROCEDURES
Immunoblotting
Total lysates and affinity precipitates were fractionated by SDS-PAGE and
transferred onto nitrocellulose filters. Immuno-complexes were visualized by
enhanced chemiluminescence detection (GE Healthcare) with horseradish
peroxidase-conjugated secondary antibodies (Bio-Rad Laboratories). Experi-
ments were repeated at least three times.
Mass Spectrometry
Cells were transfected with empty vector, a V5-tagged hydroxylase, or Flag-
tagged p53, and treated 24 hr post-transfection with either 2 mM DMOG or
DMSO for 4 hr. The cells were lysed, and we immunoprecipitated the protein
with anti-V5 or anti-Flag agarose for 2 hr. The samples were digested with
trypsin or Lys-C and processed as previously described (Turriziani et al.,
2014). Desalted peptides were analyzed on a Fusion Lumos mass spectrom-
eter (Thermo, Germany). Experiments consisted of three biological replicates
or as indicated.
Statistical Analysis
Two-tailed, equal distribution Student’s t test was employed to test for statis-
tical difference with values of *p < 0.05, **p < 0.01, and ***p < 0.001.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at https://doi.org/10.
1016/j.celrep.2018.06.108.
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